Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Self-cleaning wearable masks for respiratory infectious pathogen inactivation by type I and type II AIE photosensitizer — Jingxuan Sun (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Self-cleaning wearable masks for respiratory infectious pathogen inactivation by type I and type II AIE photosensitizer
BT
Shared by
Ben Zhong Tang
Self-cleaning wearable masks for respiratory infectious pathogen inactivation by type I and type II AIE photosensitizer
Article
2022
en
Authors
+11 more
JS
Jingxuan Sun
YB
Yujie Bai
EY
Eric Y. Yu
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis–Ferroptosis
Jiabao Zhuang
,
Bing Wang
,
Huan Chen
,
Keyi Zhang
,
Nan Li
,
Na Zhao
,
Ben Zhong Tang
Article
2025
Engineering Simple Type I AIE Photosensitizer via Donor and <i>π</i> ‐Bridge Modulations for NIR‐II Imaging‐Guided Photodynamic and Photothermal Therapy
Xinyue Yang
,
Deliang Wang
,
Jun Zhu
,
Dingyuan Yan
,
Jialin Tong
,
Yuxun Ding
,
Dong Wang
,
Guo‐Gang Shan
,
Ben Zhong Tang
Article
2023
Adipocyte-Targeting Type I AIE Photosensitizer for Obesity Treatment via Photodynamic Lipid Peroxidation
Michelle M. S. Lee
,
Dan Min Lin
,
Joe H. C. Chau
,
Eric Y. Yu
,
Dan Ding
,
Ryan T. K. Kwok
,
Dong Wang
,
Ben Zhong Tang
Article
2023
Pure Organic AIE Nanoscintillator for X‐ray Mediated Type I and Type II Photodynamic Therapy
Yuewen Yu
,
Lisha Xiang
,
Xuanwei Zhang
,
Le Zhang
,
Zhiqiang Ni
,
Zhong‐Hong Zhu
,
Yubo Liu
,
Jie Lan
,
Wei Liu
,
Ganfeng Xie
,
Guangxue Feng
,
Ben Zhong Tang
Article
2023
Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge
Shipeng Ning
,
Meng Lyu
,
Daoming Zhu
,
Jacky W. Y. Lam
,
Qinqin Huang
,
Tianfu Zhang
,
Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.